Healthcare provider profile · identity verified

Mark D Bruns, MD

Internal Medicine · INDIANAPOLIS, IN · NPI 1740248962

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	443	124
Amlodipine Besylate	Amlodipine Besylate	412	125
Losartan Potassium	Losartan Potassium	363	103
Lisinopril	Lisinopril	356	98
Metoprolol Succinate	Metoprolol Succinate	265	69
Metformin Hcl	Metformin Hcl	260	69
Levothyroxine Sodium	Levothyroxine Sodium	256	64
Gabapentin	Gabapentin	254	67
Hydrochlorothiazide	Hydrochlorothiazide	254	72
Rosuvastatin Calcium	Rosuvastatin Calcium	242	74
Omeprazole	Omeprazole	229	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	204	36
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	187	21
Alprazolam	Alprazolam	175	31
Tramadol Hcl	Tramadol Hcl	167	33
Albuterol Sulfate Hfa	Albuterol Sulfate	155	53
Pantoprazole Sodium	Pantoprazole Sodium	154	44
Simvastatin	Simvastatin	147	34
Trazodone Hcl	Trazodone Hcl	146	42
Tamsulosin Hcl	Tamsulosin Hcl	133	44
Metoprolol Tartrate	Metoprolol Tartrate	130	31
Eliquis	Apixaban	128	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	125	32
Fluticasone Propionate	Fluticasone Propionate	124	40
Famotidine	Famotidine	121	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	121	38
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	107	33
Furosemide	Furosemide	104	35
Fluoxetine Hcl	Fluoxetine Hcl	100	31
Sertraline Hcl	Sertraline Hcl	99	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	97	18
Potassium Chloride	Potassium Chloride	96	29
Clonazepam	Clonazepam	94	16
Ibuprofen	Ibuprofen	94	20
Ozempic	Semaglutide	94	17
Pravastatin Sodium	Pravastatin Sodium	91	28
Metformin Hcl Er	Metformin Hcl	89	25
Clopidogrel	Clopidogrel Bisulfate	88	19
Duloxetine Hcl	Duloxetine Hcl	85	25
Prednisone	Prednisone	85	51
Allopurinol	Allopurinol	83	26
Mirtazapine	Mirtazapine	75	25
Montelukast Sodium	Montelukast Sodium	74	23
Tizanidine Hcl	Tizanidine Hcl	74	23
Carvedilol	Carvedilol	72	22
Hydralazine Hcl	Hydralazine Hcl	69	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	67	19
Oxycodone Hcl	Oxycodone Hcl	66	suppressed
Buspirone Hcl	Buspirone Hcl	63	16
Escitalopram Oxalate	Escitalopram Oxalate	63	18
Atenolol	Atenolol	62	16
Lorazepam	Lorazepam	59	suppressed
Meloxicam	Meloxicam	59	17
Spironolactone	Spironolactone	59	14
Glipizide Er	Glipizide	55	16
Azithromycin	Azithromycin	53	42
Trulicity	Dulaglutide	50	12
Synthroid	Levothyroxine Sodium	49	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	46	13
Alendronate Sodium	Alendronate Sodium	45	11
Cephalexin	Cephalexin	45	31
Donepezil Hcl	Donepezil Hcl	44	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	15
Jardiance	Empagliflozin	39	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	15
Mounjaro	Tirzepatide	39	suppressed
Clonidine Hcl	Clonidine Hcl	38	11
Triamcinolone Acetonide	Triamcinolone Acetonide	38	31
Bupropion Xl	Bupropion Hcl	37	12
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	20
Lovastatin	Lovastatin	34	suppressed
Nystatin	Nystatin	34	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	34	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	20
Fenofibrate	Fenofibrate	32	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	32	suppressed
Novolog Flexpen	Insulin Aspart	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Amoxicillin	Amoxicillin	29	18
Estradiol	Estradiol	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Valsartan	Valsartan	29	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	28	suppressed
Finasteride	Finasteride	27	suppressed
Fluconazole	Fluconazole	27	13
Venlafaxine Hcl	Venlafaxine Hcl	27	suppressed
Colchicine	Colchicine	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Diazepam	Diazepam	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Hydrocortisone	Hydrocortisone	22	suppressed
Naproxen	Naproxen	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	21	12
Farxiga	Dapagliflozin Propanediol	21	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Topiramate	Topiramate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Novolog	Insulin Aspart	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Oxycontin	Oxycodone Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Ammonium Lactate	Ammonium Lactate	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Methylprednisolone	Methylprednisolone	15	11
Mupirocin	Mupirocin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Baclofen	Baclofen	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error